Community Board
Investment Case · Oct 19, 2026
Closed
0

$CRWV

LONG
CoreWeave, Inc. - Class A · Nasdaq
Credit Panic Has Overshot Contracted Demand
J@joe @joe7 cases · 0% hit · +2.3% avgConviction 3/5 12-18 months, with the Q3 2026 print (expected Nov 11) as the first checkpoint
Thesis

The October sell-off is a credit-sentiment shock, not an operating deterioration. At about $61, CRWV prices heavy default risk against a $104B backlog, rising margins and asset-backed funding that costs far less than its distressed unsecured bonds imply.

Performance Since Publication
Against the thesis
Return
-9.4%
At Publication
$61.39
Last
$55.60
To Target
+90.7%
STOP$56.00AT PUBLICATION$61.39PRICE TARGET$106.00LAST$55.60
Company Snapshot
CoreWeave, Inc. Class A Common Stock
Services-Prepackaged Software
Large Cap
Market Cap
$35.3B
P/E (TTM)
—
Dividend Yield
—
Beta
—
Avg Volume
—
200-Day Avg
—
Next Earnings
—
Employees
2.2K

CoreWeave is a modern cloud infrastructure company that offers Nvidia GPUs and other essential AI hardware with optimized efficiency to handle the most demanding AI training and inference workloads. Its cloud platform supports the development and use of foundational large language models and the delivery of next-generation AI applications to satisfy the…

www.coreweave.com
Price Levels
Entry
$60.50
Price Target
$106.00
Stop
$56.00
How These Levels Were Set

Support 59.51 is the 52-week low set on Oct 15, 2026 (CNBC). The $60.57 level cited by TradingKey sits just above it. Entry 60.50 is set at that support zone, near the Oct 16 close of 61.39 and the Oct 19 intraday low of 59.65 (Yahoo). Price target 106.00 is Goldman's Oct 19 target, about 73% above the 61.39 close. It is still below the consensus average of about $137-146 and well below the Aug 12 post-earnings level near $102 after hours plus follow-through. Stop 56.00 is my reference point, roughly 6% below the 52-week low, so a break would mean the low failed. It is wide on purpose given daily moves of 12-15%; adjust to your risk budget. Resistance 78.85 is the level TradingKey identifies as the overhead barrier in the current downtrend.

Catalysts
  1. 1Q3 2026 earnings, listed by Yahoo Finance as Nov 11, 2026 (confirm with company): revenue vs $3.4B-$3.6B guide, adjusted operating income vs $200M-$260M, int…
  2. 2Backlog update: whether the more than $25B of early-Q3 commitments converts into a figure well above $104.2B
  3. 3New asset-backed or DDTL financing announcements and their pricing, which would test Goldman's view of marginal funding cost
  4. 4Credit gauges: recovery in the 2031 and 2032 unsecured notes (recently around 78-79 cents on the dollar) and a retreat from record CDS levels
  5. 5Capacity ramp: active power versus the 1.5 GW at June 30, first-to-production Vera Rubin NVL72 deployments, and the rate-card increases cited by bulls
Key Risks
  1. 1Refinancing and dilution: about $51.6B of debt and leases, bonds yielding near 15%, and a Deutsche Bank estimate of a roughly $35B funding gap. If asset-back…
  2. 2Interest burden: Q2 net interest of $640M turned roughly breakeven operations into a $626M net loss. Q3 interest is guided to $860M-$940M against adjusted op…
  3. 3Customer concentration: per ValueAdd, three customers including Microsoft and OpenAI account for 72% of revenue. Take-or-pay protection depends on counterpar…
  4. 4Macro and sentiment: the sell-off coincided with higher-rate fears, IMF warnings on an AI-related correction and Oracle weakness. The stock sits below its 50…
  5. 5Bear analysts: D.A. Davidson (sell, $36 PT) calls the balance sheet among the weakest in tech, and Redburn (sell, $54 PT) sits below the current price.
Read the Full Thesis
What the market is pricing: CRWV fell 24% in five sessions to close at $61.39 on Oct 16, and is down 43% since the Aug 11 Q2 report, per Goldman Sachs. The 52-week low is 59.51 (Oct 15) against a high of 141.79 (Oct 28, 2025), per CNBC. The trigger was credit. Per CNBC on Oct 14, the 2032 notes yielded 14.8%. Per Motley Fool, five-year CDS hit a record of about 1,195 bp. Debt and leases totaled roughly $51.6B at June 30, per the Q2 filing as reported. Why the long side may be right: operations moved the other way. Q2 revenue was $2.58B (+112% y/y), beating the $2.56B LSEG consensus. Adjusted operating income was $128M versus $21M in Q1. Backlog was $104.2B (+246%), and it excludes more than $25B of net new commitments signed in early Q3, per the Q2 release. FY26 revenue guidance was raised to $12.4B-$13.2B and adjusted operating income to $960M-$1.15B. Q3 guidance is $3.4B-$3.6B of revenue and $200M-$260M of adjusted operating income. The financing argument: Goldman Sachs (upgrade to Buy, Oct 19, PT $106) notes that CoreWeave's main funding route is asset-backed delayed-draw term loans, not unsecured bonds. It says the unsecured market has been closed to the company for months, so 13.5%-15% bond yields overstate the marginal cost of capital. Supporting data points: an August $2.6B facility priced at SOFR plus 5.5 points, and a 5.9% rate on a Meta-backed tranche in July per SemiAnalysis. Goldman models blended debt cost up only 100-200 bp. It also sees annual revenue per MW rising from about $10M to $13M. Valuation and expectations: consensus targets sit around $137-146 depending on source (MarketBeat $137.35, S&P Global via StockAnalysis $140.58), with a range of $39 to $278. The shares trade at under half of that average, with the intraday low on Oct 19 holding just above the Oct 15 low. What has to be true: (1) asset-backed financing stays available at single-digit to low-teens spreads for the roughly $35B funding gap Deutsche Bank estimates; (2) Q3 shows margin expansion large enough to start covering interest, guided at $860M-$940M; (3) Microsoft, Meta, OpenAI and Anthropic keep drawing capacity on schedule; (4) credit indicators (bond prices, CDS) stabilize rather than make new lows. If these hold, the bottom is in place and equity value re-rates toward the backlog.
Updates Since Publication
  1. Oct 19, 2026 · Price 62.89

    Weekly check-in: On Track. Goldman upgrade backs financing argument, but credit gauges have not yet stabilized The only new evidence this week is analyst commentary and price action. There is no new earnings report, guidance change or financing print. Goldman's Oct 19 upgrade to Buy (PT $106) adopts the case's asset-backed funding argument. But Goldman also cut its target from $139 and its forward EBIT multiple from 22x to 18x, and MoffettNathanson cut to $89 and stayed Neutral. Credit stress, the trigger in the case, has not yet reversed. The thesis is intact but still unconfirmed until Q3 and new financing pricing arrive.

  2. Oct 24, 2026 · Price 55.60

    Stop hit on Oct 24 at 55.60. Close the case and note what you learned, or move the level if your view changed.

  3. Oct 24, 2026

    Too tight of stop.

  4. Oct 24, 2026 · Case Closed

    Stop hit on Oct 23 at $55.60

The Other Side

Disagree? Make the opposite case with your own levels. Both get scored, so the debate gets a winner.

Track This Case

Copy it into your own account, adjust it to your view, and get an alert when the price reaches its levels.

Discussion
Do You Agree With @joe?
agreedisagree
No one has weighed in yet. Be the first. A stance is a reader's view, not advice.
Be specific and civil. No promotion or price-pumping. Comments are checked before they appear. Guidelines

No comments yet. Start the discussion with the point you'd want the author to answer.

Investment case published by @joe. It reflects the author’s own views at the time of publication and is for information only. It is not investment advice or a recommendation to buy or sell any security. Prices and company data are delayed and may be inaccurate. User content is not verified. · How we measure performance

Long $CRWV | Investment Case. The October sell-off is a credit-sentiment shock, not an operating deterioration. At about $61, CRWV prices heavy default risk against a $104B backlog, rising margins and asset-…